Rebalix
Logo InvescoInvesco · sheet of 10 September 2026
ETF sheet · official issuer and register data

Invesco KBW NASDAQ Fintech UCITS ETF Acc

FTEK · IE00BYMS5W68 · class Acc · USD · domicile Ireland
Equity · United States · TechnologySFDR art. 6
Index tracked: KBW NASDAQ Financial Technology Total Return (Net) Index
TER
0.49%+ trans. 0.10%
Fund size
57 m EUR
Tracking difference
−0.59%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Synthetic (swap)
Income
Accumulating
Launch 8 Mar 2017 · costs from the KID as of 14 Aug 2026 · 57 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to achieve the net total return performance of the KBW NASDAQ Financial Technology Index (the "Index"), less fees, expenses and transaction costs. Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the…

Performance since series start (in euro) — base 100

8 Mar 201713 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2018202020222024202630995267
High 309 (25 Nov 2024) · low 95 (18 May 2017) · last 267. Past performance is not indicative of future results.

Returns in euro

1 year−3.9%
3 years+48.9%
5 years+23.8%
10 yearsseries too young
Since series start+166.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)24.96%22.51%24.38%
Max drawdown−25.40%−25.84%−38.10%
Sharpe-0.320.610.15
Sortino-0.430.860.22
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · FTEK · IE00BYMS5W681
RebalixFTEK · IE00BYMS5W68 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025−0.51%+0.01%−0.52%
2024+33.78%+34.44%−0.66%
2023+32.85%+33.44%−0.59%
2022−31.84%−31.52%−0.32%
2021+9.55%+10.08%−0.53%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 31 Aug 2026 · 57 securities · top-10 weight = 52.7%
Top holdingsWeight
SENTINELONE INC -CLASS A9.3%
NXP SEMICONDUCTORS NV8.7%
NU HOLDINGS LTD/CAYMAN ISL-A7.1%
BROADCOM INC5.4%
DYNATRACE INC3.9%
CORECIVIC INC3.8%
PERFORMANCE FOOD GROUP CO3.8%
ASCENDIS PHARMA A/S3.7%
CELCUITY INC3.6%
MADISON SQUARE GARDEN ENTERT3.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
KFTK · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 14 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BYMS5W68
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · FTEK · IE00BYMS5W682